DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study

Iglicki, Matias; Busch, Catharina; Zur, Dinah; Okada, Mali; Mariussi, Miriana; Chhablani, Jay; Cebeci, Zafer; Fraser-Bell, Samantha; Chaikitmongkol, Voraporn; Couturier, Aude; Giancipoli, Ermete; Lupidi, Marco; Rodriguez-Valdes, Patricio; Rehak, Matus; Fung, Adrian; Goldstein, Michaella; Loewenstein, Anat

doi:10.1097/iae.0000000000002196

DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study

Copy For Citation

Iglicki M., Busch C., Zur D., Okada M., Mariussi M., Chhablani J. K., ...More

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, vol.39, no.1, pp.44-51, 2019 (SCI-Expanded)

Publication Type: Article / Article
Volume: 39 Issue: 1
Publication Date: 2019
Doi Number: 10.1097/iae.0000000000002196
Journal Name: RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.44-51
Istanbul University Affiliated: Yes

Abstract

Purpose: To investigate efficacy and safety of repeated dexamethasone (DEX) implants over 24 months, in diabetic macular edema (DME) eyes that were treatment naive compared with eyes refractory to anti-vascular endothelial growth factor treatment, in a real-life environment.